Version 1
: Received: 17 October 2024 / Approved: 17 October 2024 / Online: 18 October 2024 (08:28:41 CEST)
How to cite:
Naisam, S.; Mohan, A.; S S, G.; V S, V.; V S, V.; Sreekumar, N. NAADISASYA: An Ayurinformatic Study on Alzheimer’s and Parkinson’s Diseases. Preprints2024, 2024101378. https://doi.org/10.20944/preprints202410.1378.v1
Naisam, S.; Mohan, A.; S S, G.; V S, V.; V S, V.; Sreekumar, N. NAADISASYA: An Ayurinformatic Study on Alzheimer’s and Parkinson’s Diseases. Preprints 2024, 2024101378. https://doi.org/10.20944/preprints202410.1378.v1
Naisam, S.; Mohan, A.; S S, G.; V S, V.; V S, V.; Sreekumar, N. NAADISASYA: An Ayurinformatic Study on Alzheimer’s and Parkinson’s Diseases. Preprints2024, 2024101378. https://doi.org/10.20944/preprints202410.1378.v1
APA Style
Naisam, S., Mohan, A., S S, G., V S, V., V S, V., & Sreekumar, N. (2024). NAADISASYA: An Ayurinformatic Study on Alzheimer’s and Parkinson’s Diseases. Preprints. https://doi.org/10.20944/preprints202410.1378.v1
Chicago/Turabian Style
Naisam, S., Viji V S and Nidhin Sreekumar. 2024 "NAADISASYA: An Ayurinformatic Study on Alzheimer’s and Parkinson’s Diseases" Preprints. https://doi.org/10.20944/preprints202410.1378.v1
Abstract
Alzheimer's disease (AD) and Parkinson's disease (PD) are the most prevalent and irreversible neurological disorders that primarily affect the aged population. These conditions lead to disability and mortality as there is currently no medication for a complete cure. Existing drugs only provide symptomatic relief of the disease. Inhibition of Acetylcholinesterase (AChE) and Butyrylcholinesterase (BuChE) will reduce the hydroxylation of Acetylcholine, a molecule possessing a significant role in the neurotransmission pathways and is accounted as a remedial objective for the treatment of AD and PD. This study aimed to identify potent lead molecules from plants that could inhibit AChE and BuChE. We employed molecular docking, molecular dynamic simulation, and MMPBSA approaches to screen and evaluate potential compounds. The docking results were analysed based on binding affinity and hydrogen bond interactions at the active-site residues of the targets. From the analysis, four phytocompounds - Tricetin, Luteolin, Withasomniferol C, and Withanolide were identified as potential hits. These compounds demonstrated strong binding affinities of -8.49, -9.85, -25.26, and -24.1 kcal/mol, respectively. The significant binding affinity suggests that these compounds may effectively inhibit the activity of AChE and BuChE, potentially leading to therapeutic benefits for AD and PD. However, further in-vitro analysis is recommended to validate the activity of these compounds. In-vitro experiments will provide a better understanding of their efficacy, safety, and potential as drug candidates for treating AD and PD.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
